Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts

Kaohsiung Journal of Medical Sciences

Volumn 29, Issue 6, 2013, Pages 312-318

  Lin, Zu Yau ^a,b   Chuang, Wan Long ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cancer associated fibroblast; Gene expression; Hepatocellular carcinoma; Migration; Proliferation

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MUCIN 1; PHOSPHOGLYCERATE KINASE 1; PLATELET DERIVED GROWTH FACTOR A; PROTEIN LYSINE 6 OXIDASE; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; TUMOR GENE; TUMOR INVASION; TUMOR MICROENVIRONMENT; UPREGULATION;

CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84877874081     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kjms.2012.08.012     Document Type: Article

References (42)

1. F. Xing, J. Saidou, and K. Watabe Cancer associated fibroblasts (CAFs) in tumor microenvironment Front Biosci 15 2010 166 179
2. M. Shimoda, K.T. Mellody, and A. Orimo Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression Semin Cell Dev Biol 21 2010 19 25
3. P. Mishra, D. Banerjee, and A. Ben-Baruch Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy J Leukoc Biol 89 2011 31 39
4. J.D. Yang, I. Nakamura, and L.R. Roberts The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets Semin Cancer Biol 21 2011 35 43
5. A. Mazzocca, F. Dituri, L. Lupo, M. Quaranta, S. Antonaci, and G. Giannelli Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts Hepatology 54 2011 920 930
6. K. Schutte, J. Bornschein, and P. Malfertheiner Hepatocellular carcinoma-epidemiological trends and risk factors Dig Dis 27 2009 80 92
7. P. Abrams, and J.W. Marsh Current approach to hepatocellular carcinoma Surg Clin North Am 90 2010 803 816
8. Lin ZY, Chuang YH, Chuang WL. Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells. Biomed Pharmacother 2012 Mar 27. [Epub ahead of print].
9. M. Sonnenberg, H. van der Kuip, S. Haubeis, P. Fritz, W. Schroth, and G. Friedel Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast BMC Cancer 8 2008 364
10. Z.Y. Lin, W.L. Chuang, and Y.H. Chuang Amphotericin B up-regulates angiogenic genes in hepatocellular carcinoma cell lines Eur J Clin Invest 39 2009 239 245
11. Z.Y. Lin, and W.L. Chuang Pharmacologic concentrations of ascorbic acid cause diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines Biomed Pharmacother 64 2010 348 351
12. Z.Y. Lin, and W.L. Chuang Pharmacologic concentrations of melatonin have diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines Biomed Pharmacother 64 2010 659 662
13. C.S. Changchien, J.H. Wang, S.N. Lu, C.H. Hung, C.H. Chen, and C.M. Lee Liu-stain quick cytodiagnosis of ultrasound-guided fine needle aspiration in diagnosis of liver tumors World J Gastroenterol 13 2007 448 451
14. J. Wang, G. Ying, J. Wang, Y. Jung, J. Lu, and J. Zhu Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression Cancer Res 70 2010 471 480
15. S. Bouleau, H. Grimal, V. Rincheval, N. Godefroy, B. Mignotte, and J.L. Vayssière FGF1 inhibits p53-dependent apoptosis and cell cycle arrest via an intracrine pathway Oncogene 24 2005 7839 7849
16. M.L. Henriksson, S. Edin, A.M. Dahlin, P.A. Oldenborg, and Van Guelpen B. Öberg Å Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion Am J Pathol 178 2011 1387 1394
17. C.H. Chen, S.M. Poucher, J. Lu, and P.D. Henry Fibroblast growth factor 2: from laboratory evidence to clinical application Curr Vasc Pharmacol 2 2004 33 43
18. J. Yang, J. Wang, J. Zhao, D. Zuo, X. Li, and L. Wang Influence of basic fibroblast growth factor on the growth of HeLa cells and the expression of angiogenin Oncol Rep 21 2009 949 955
19. M. Korc, and R.E. Friesel The role of fibroblast growth factors in tumor growth Curr Cancer Drug Targets 9 2009 639 651
20. M. Presta, G. Andrés, D. Leali, P. Dell'Era, and R. Ronca Inflammatory cells and chemokines sustain FGF2-induced angiogenesis Eur Cytokine Netw 20 2009 39 50
21. L. Lin, R. Amin, G.I. Gallicano, E. Glasgow, W. Jogunoori, and J.M. Jessup The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling Oncogene 28 2009 961 972
22. M. Ando, I. Uehara, K. Kogure, Y. Asano, W. Nakajima, and Y. Abe Interleukin 6 enhances glycolysis through expression of the glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 J Nihon Med Sch 77 2010 97 105
23. Y. Liu, P.K. Li, C. Li, and J. Lin Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells J Biol Chem 285 2010 27429 27439
24. Y. Fan, J. Ye, F. Shen, Y. Zhu, Y. Yeghiazarians, and W. Zhu Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro J Cereb Blood Flow Metab 28 2008 90 98
25. E.L. Spaeth, J.L. Dembinski, A.K. Sasser, K. Watson, A. Klopp, and B. Hall Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression PLoS One 4 2009 e4992
26. R. Ahmad, H. Rajabi, M. Kosugi, M.D. Joshi, M. Alam, and B. Vasir MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop Sci Signal 4 2011 ra9
27. L.D. Roy, M. Sahraei, D.B. Subramani, D. Besmer, S. Nath, and T.L. Tinder MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition Oncogene 30 2011 1449 1459
28. K. Kinoshita, K. Nakagawa, J. Hamada, Y. Hida, M. Tada, and S. Kondo Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells Int J Oncol 37 2010 869 877
29. M. Eyries, G. Siegfried, M. Ciumas, K. Montagne, M. Agrapart, and F. Lebrin Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis Circ Res 103 2008 432 440
30. A. Kasai, Y. Ishimaru, T. Kinjo, T. Satooka, N. Matsumoto, and Y. Yoshioka Apelin is a crucial factor for hypoxia-induced retinal angiogenesis Arterioscler Thromb Vasc Biol 30 2010 2182 2187
31. J. Berta, I. Kenessey, J. Dobos, J. Tovari, W. Klepetko, and H. Jan Ankersmit Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis J Thorac Oncol 5 2010 1120 1129
32. S. Shinkaruk, M. Bayle, G. Laïn, and G. Déléris Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy Curr Med Chem Anticancer Agents 3 2003 95 117
33. M. Shibuya Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis BMB Rep 41 2008 278 286
34. Y.M. Kim, E.C. Kim, and Y. Kim The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin Mol Biol Rep 38 2011 145 149
35. V. Brekhman, J. Lugassie, S. Zaffryar-Eilot, E. Sabo, O. Kessler, and V. Smith Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2 FASEB J 25 2011 55 65
36. L. Peng, Y.L. Ran, H. Hu, L. Yu, Q. Liu, and Z. Zhou Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway Carcinogenesis 30 2009 1660 1669
37. M. Sano, K. Aoyagi, H. Takahashi, T. Kawamura, T. Mabuchi, and H. Igaki Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis Int J Oncol 36 2010 321 330
38. H.E. Barker, J. Chang, T.R. Cox, G. Lang, D. Bird, and M. Nicolau LOXL2-mediated matrix remodeling in metastasis and mammary gland involution Cancer Res 71 2011 1561 1572
39. J.G. Herman, H.L. Stadelman, and C.E. Roselli Curcumin blocks CCL2-induced adhesion, motility and invasion, in part, through down-regulation of CCL2 expression and proteolytic activity Int J Oncol 34 2009 1319 1327
40. M. Ohta, Y. Kitadai, S. Tanaka, M. Yoshihara, W. Yasui, and N. Mukaida Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas Int J Cancer 102 2002 220 224
41. M. Ohta, Y. Kitadai, S. Tanaka, M. Yoshihara, W. Yasui, and N. Mukaida Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas Int J Oncol 22 2003 773 778
42. C. Murdoch, M. Muthana, S.B. Coffelt, and C.E. Lewis The role of myeloid cells in the promotion of tumour angiogenesis Nat Rev Cancer 8 2008 618 631